Publications
Publications
Show Results For
- All HBS Web
(1,022)
- Faculty Publications (288)
Patents
→
- October 2004 (Revised March 2005)
- Case
Langer Lab, The: Commercializing Science
By: H. Kent Bowen, Alex Kazaks, Ayr Muir-Harmony and Bryce LaPierre
Professor Robert Langer's laboratory at MIT is the source of an unusually large number of published papers, patents, and technology licenses to start-up and established companies in the biomedical industry. Explores Langer's leadership and other factors that create a... View Details
- 2004
- Other Presentation
International Patenting and the European Patent Office: A Quantitative Assessment
By: Josh Lerner, Jonathan Eaton and Samuel Kortum
- May 2004
- Background Note
56K Modem Battle
By: David B. Yoffie and Deborah Freier
Examines the battle to set the standard for the 56K modem. Set in 1996, this case looks at how computers accessed the Internet via a telephone line, or dial-up connection, and a hardware modem. In 1995, there were 18.6 million total modem unit shipments, with market... View Details
- May 2004 (Revised April 2005)
- Background Note
Intellectual Property and Strategy
By: David B. Yoffie and Deborah Freier
Explores the role of intellectual property in firms' strategies. Explains the legal and strategic differences between patents, copyrights, trademarks, and trade secrets and explores the multiple ways firms use these different legal protections to gain competitive... View Details
- May 2004
- Article
Was Electricity a General Purpose Technology: Evidence from Historical Patent Citations
By: Tom Nicholas and Petra Moser
- Article
Little Patents and Big Secrets: Managing Intellectual Property
By: James J. Anton and Dennis A. Yao
Exploitation of an innovation commonly requires some disclosure of enabling knowledge (e.g., to obtain a patent or induce complementary investment). When property rights offer only limited protection, the value of the disclosure is offset by the increased threat of... View Details
Keywords: Patents; Management; Innovation and Invention; Knowledge; Rights; Value; Information; Corporate Disclosure
- Article
Why Schumpeter Was Right: Innovation, Market Power and Creative Destruction in 1920s America
By: Tom Nicholas
Are firms with strong market positions powerful engines of technological progress? Joseph Schumpeter thought so, but his hypothesis has proved difficult to verify empirically. This article highlights Schumpeterian market-power and creative-destruction effects in a... View Details
- summer 2003
- Article
Patents, Invalidity, and the Strategic Transmission of Enabling Information
By: James J. Anton and Dennis A. Yao
The patent system encourages innovation and knowledge disclosure by providing exclusivity to inventors. Exclusivity is limited, however, because a substantial fraction of patents have some probability of being ruled invalid when challenged in court. The possibility of... View Details
- June 2003 (Revised May 2006)
- Case
Cipla
By: Rohit Deshpande and Laura Winig
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details
- May 2003
- Teaching Note
Performance Indicator (TN)
By: Kenneth S. Corts and Jan W. Rivkin
Teaching Note for (9-702-480). View Details
- October 2002 (Revised October 2003)
- Case
Aspen Aerogels
By: William A. Sahlman and Taslim Pirmohamed
Describes a newly formed manufacturer of insulation materials. The company has developed and patented a new insulation material that can be used in a wide range of markets. Capital must be raised to finance building a manufacturing facility and fund early market... View Details
- June 2002 (Revised November 2005)
- Case
Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa
By: Debora L. Spar
In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details
- May 2002 (Revised October 2005)
- Case
Marketing Antidepressants: Prozac and Paxil
By: Youngme E. Moon and Kerry Herman
Describes the marketing of Prozac and Paxil, two of the best-selling mental health drugs in history. Set in 2001, several months before the expiration of Prozac's patent, Eli Lilly (Prozac's manufacturer) and GlaxoSmithKline (Paxil's manufacturer) must decide how to... View Details
- April 2002
- Article
Where Does State Street Lead? A First Look at Finance Patents, 1971-2000
By: Josh Lerner
- February 2002
- Case
Fighting AIDS and Pricing Drugs
In early 2001, makers of AIDS drugs were suing to prevent developing countries from violating their patents. The issue was driven by price. The developing countries could not afford the market price for these drugs. At the same time, the drug companies were reluctant... View Details
- January 2002
- Article
Putting Patents in Context: Exploring Knowledge Transfer from MIT
By: Ajay Agrawal and Rebecca M. Henderson